Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment
- Aideen M Campbell
- , Melanie Morris
- , Rebecca Gallagher
- , Ruth Boyd
- , Hazel Carson
- , D Paul Harkin
- , Ewa Wielogorska
- , Christopher Elliott
- , Kienan I Savage
- , Stuart A McIntosh
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Citations
(Scopus)
254
Downloads
(Pure)